跳至主要内容
临床试验/NCT04099121
NCT04099121已完成不适用

Evaluation of 3D Ultrasound Vaginal Manometry for Estimating the Optimal Pessary Size for Patients With Pelvic Organ Prolapse

Western University, Canada2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2020年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24
试验地点
2
主要终点
FEASIBILITY: The predicted pessary shape

研究概览

简要总结

Symptoms of female pelvic floor dysfunction, such as incontinence and pelvic organ prolapse, can be alleviated by using pessaries, which are passive medical devices that are inserted in the vagina to support the pelvic organs. Currently, pessaries are fit through trial and error after manual examination, the accuracy of which depends on the physician's expertise level.

The objective of this study is to evaluate the feasibility of using 3D translabial ultrasound imaging of the vagina at various distension volumes to predict the pessary size for successful fit. Ultrasound images will be obtained using commercially available 3D ultrasound probes (Philips, Netherlands), as well as a commercially available 2D ultrasound probe (Philips, Netherlands), which is linearly scanned to capture a 3D volume. The linear scanning will be performed by attaching the 2D probe to a motorized hand-held scanner, which is used to tilt and move the probe to acquire images. Please note that the hand-held scanner does not come in contact with the patient. To distend the vagina, a sterile bag is inserted in the vagina and gradually filled with water using a commercially available urodynamic system (Laborie, Canada) until the vaginal capacity is reached, without causing any discomfort to the patient. This image acquisition technique, previously reported in the literature, is referred to as 3D ultrasound vaginal manometry in this study.

To achieve the objective of this project, 35 pelvic organ prolapse patients, who (i) are current pessary users, (ii) can perform self-care of the pessary, and (iii) can provide informed consent, will be invited to participate in the study. Patients will be asked to remove their pessary prior to ultrasound imaging. Then, 3D ultrasound vaginal manometry will be performed, using the technique described above. Ultrasound images will be analyzed once data acquisition is completed. The size of the pessary estimated from ultrasound images will be compared with the actual pessary size used by the patient.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

性别
Female
接受健康志愿者

入选标准

  • Current pessary users (> 6 months) who have no pessary related complication, including discomfort, repeated vaginal bleeding, and pessary extrusion
  • Are able to provide informed consent
  • Can perform self-care, i.e. removing and inserting the pessary themselves
  • Are willing to remove their pessary 2 days before the ultrasound examination date.

排除标准

  • Inability to give informed consent
  • Inability to communicate with the person performing the consent and the sonographer performing ultrasound scanning
  • History of pelvic radiation or surgery, (including hysterectomy)
  • Using pessaries other than ring, incontinence dish, donut, Shaatz, Marland, or Gellhorn.
  • Inability to perform the Valsalva maneuver or pelvic floor contraction
  • Restricted mobility that prevents them from ambulating to assess the comfort level of the pessary during the initial pessary fitting visit.
  • Lack of sensation at the pelvic floor.
  • Being pregnant at the time of the examination.

结局指标

主要结局

FEASIBILITY: The predicted pessary shape

时间窗: Up to 3 months following data collection

The predicted pessary shape will be compared with the actual shape of the pessary used by the patient by calculating the DICE coefficient.

FEASIBILITY: The predicted pessary size

时间窗: Up to 3 months following data collection

The predicted pessary size in cubic mm will be compared with the actual size of the pessary used by the patient

次要结局

未报告次要终点

研究者

发起方
Western University, Canada
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Evaluation of 3D Translabial Ultrasound Imaging for... | 临床试验